These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 674996)

  • 1. [Analysis of 280,000 Kell determinations by Groupamatic].
    Garretta M; Gener J; Muller A
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):379-86. PubMed ID: 674996
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phenotyping Kell and Duffy antigens by a technic of coagglutination on the Groupamatic G 360].
    Soustelle B; Rubio F; Coves F; Bizot M
    Rev Fr Transfus Immunohematol; 1982 Jun; 25(3):309-19. PubMed ID: 7111980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO group determination with the use of four channels on Groupamatic.
    Pirkola A; Leikola J; Nevanlinna HR
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):305-9. PubMed ID: 674994
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of Le (a) antigen determination by Groupamatic].
    Chassaigne M; Muller A; Saint-Paul B; Garretta M
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):387-95. PubMed ID: 674997
    [No Abstract]   [Full Text] [Related]  

  • 5. Semi-automated recording system in connection with routine blood grouping of patients and donors on Groupamatic 360 C.
    Freiesleben E; Christiansen U; Hansen SA; Madsen G; Sorensen H
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):593-601. PubMed ID: 675009
    [No Abstract]   [Full Text] [Related]  

  • 6. Groupamatic types 360 C-3, 360 S and MG 50 at work for automatisation of a national blood-transfusion-service. A comparative study.
    Gathof GE; Gathof B; Schulze S; Gathof AG
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):705-12. PubMed ID: 97764
    [No Abstract]   [Full Text] [Related]  

  • 7. A solid phase antibody screen.
    Plapp FV; Sinor LT; Rachel JM; Beck ML; Coenen WM; Bayer WL
    Am J Clin Pathol; 1984 Dec; 82(6):719-21. PubMed ID: 6507384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of non-diagnosing of Groupamatic 360-C3; Vienna (June-September 1976).
    Speiser P
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):297-301. PubMed ID: 97751
    [No Abstract]   [Full Text] [Related]  

  • 9. Some factors, influencing the sensitivity of the antibody screening the Groupamatic 360 system.
    Messeter L
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):485-94. PubMed ID: 97759
    [No Abstract]   [Full Text] [Related]  

  • 10. The present state of HBsAg detection (without Groupamatic).
    Seidl S
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):503-8. PubMed ID: 353950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of the BG 15 autoanalyzer for automatic recording and determination of ABO, Rhesus and Kell blood groups].
    Girard M; Michaud C
    Rev Fr Transfus Immunohematol; 1979 Jun; 22(3):265-74. PubMed ID: 115076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curve regenerationin modified LISP and DISP AutoAnalyzer haemagglutination channels.
    Crockford J; Moore BP
    J Clin Pathol; 1979 Aug; 32(8):848-51. PubMed ID: 512044
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of irregular alloantibodies by Groupamatic using a trypsin-polybrene-citrate technic].
    Confida S; Hurel C; Muller A; Garretta M
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):457-72. PubMed ID: 97758
    [No Abstract]   [Full Text] [Related]  

  • 14. PVP-augmented LISP and DISP AutoAnalyzer haemagglutination channels.
    Crockford J; Moore BP
    J Clin Pathol; 1979 Aug; 32(8):845-8. PubMed ID: 512043
    [No Abstract]   [Full Text] [Related]  

  • 15. Groupamatic system: overview, history of development and evaluation of use.
    Muller A; Garretta M; Hebert M
    Vox Sang; 1981 Mar; 40(3):201-13. PubMed ID: 6787802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kell antigen in people of Siena (author's transl)].
    Fanetti G
    Quad Sclavo Diagn; 1976 Sep; 12(3):253-7. PubMed ID: 67610
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary study on the incidence of Kell antigen in the province of Potenza].
    Florio F; Milito S
    Minerva Med; 1977 Jan; 68(3):151-5. PubMed ID: 840407
    [No Abstract]   [Full Text] [Related]  

  • 18. An example of naturally occurring anti-Kell (K1) in a Japanese male.
    Mukumoto Y; Konishi H; Ito K; Seno T; Okubo Y
    Vox Sang; 1978; 35(4):275-6. PubMed ID: 695444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HBs antigen screening with Groupamatic. Inhibition of passive hemagglutination and latex test].
    Soulier JP; Garretta M; Benamon D; Drouet J; Courouce-Pauty AM
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):511-21. PubMed ID: 675004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two additional examples of non-transfusion-stimulated anti-Kell.
    Clark A; Monaghan WP; Martin CA
    Am J Med Technol; 1981 Dec; 47(12):983-4. PubMed ID: 7332023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.